Priapism in Sickle Cell Anemia: Emerging Mechanistic Understanding and Better Preventative Strategies
Author(s) -
Genevieve M. Crane,
Nelson Bennett
Publication year - 2010
Publication title -
anemia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.921
H-Index - 25
eISSN - 2090-1275
pISSN - 2090-1267
DOI - 10.1155/2011/297364
Subject(s) - priapism , medicine , disease , erectile dysfunction , intensive care medicine , sickle cell anemia , bioinformatics , surgery , biology
Sickle cell anemia is a common and disabling disorder profoundly affecting mortality as well as quality of life. Up to 35% of men with sickle cell disease are affected by painful, prolonged erections termed ischemic priapism. A priapic episode may result in fibrosis and permanent erectile dysfunction. The severity of sickle cell disease manifestations is variable dependent on a number of contributing genetic factors; however, priapism tends to cluster with other severe vascular complications including pulmonary hypertension, leg ulceration, and overall risk of death. The mechanisms underlying priapism in sickle cell disease have begun to be elucidated including hemolysis-mediated dysregulation of the nitric oxide signaling pathway and dysregulation of adenosine-mediated vasodilation. A better understanding of these mechanisms is leading toward novel preventative strategies. This paper will focus on the mechanisms underlying development of ischemic priapism in sickle cell disease, current acute and preventative treatment strategies, and future directions for improved management of this disorder.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom